Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
33.93%
↑ 102% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-1647.51%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 33.93% | +70.8% |
| 2025 | 19.87% | +100.1% |
| 2024 | -15812.81% | -21569.3% |
| 2023 | -72.97% | -9.4% |
| 2022 | -66.72% | +30.4% |
| 2021 | -95.87% | +3.3% |
| 2020 | -99.12% | -354.9% |
| 2019 | 38.88% | +112.2% |
| 2018 | -317.41% | -208.6% |
| 2017 | -102.86% | - |